Abbreviations
From Cancer Guidelines Wiki
Clinical practice guidelines for the treatment of lung cancer > Abbreviations
Author(s):
Guidelines commissioned by
Last modified:
7 March 2014 03:59:08
Abbreviations
| 2G | Second generation |
| 3D | Three-dimensional |
| 3G | Third generation |
| ACCP | American College of Chest Physicians |
| ACP | Advance care planning |
| ADLS | Activities of Daily Living Scale |
| AI | Angiogenesis inhibitors |
| ALK | Anaplastic lymphoma kinase |
| ANITA | Adjuvant Navelbine International Trialist Association |
| BAE | Bronchial artery embolisation |
| BED | Biologically equivalent dose |
| BTS | British Thoracic Society |
| CAI | Carboxyaminotriazole |
| CALGB | Cancer and Leukemia Group B trial group |
| CBT | Cognitive Behaviour Therapy |
| CHART | Continuous, hyperfractionated, accelerated radiotherapy |
| CHARTWEL | CHART weekend-less |
| CI | Confidence intervals |
| CNS | Central nervous system |
| COPD | Chronic obstructive pulmonary disease |
| CPR | Cardio pulmonary resuscitation |
| CRT | Chemoradiotherapy |
| CT scan | Computed tomography scan |
| CTV | Clinical Target Volume |
| DRR | Digitally reconstructed radiographs |
| DVHs | Dose volume histograms |
| EBUS | Endo bronchial ultrasound |
| EML4 | Echinoderm microtubule-associated protein-like 4 |
| ECOG PS | Eastern Cooperative Oncology Group Performance Status |
| EGFR | Epidermal growth factor receptor |
| ENI | Elective nodal irradiation |
| EORTC | European Organisation for Research and Treatment of Cancer |
| FEV1 | Forced expiratory volume in one second |
| FIS | Functional independent survival |
| FNA | Fine needle aspiration |
| GA | General anaesthesia |
| GTV | Gross Tumour Volume |
| HART | Hyperfractionated accelerated radiotherapy |
| HR | Hazard ratio |
| HRQOL | Health-related quality of life |
| HVLT | Hopkins Verbal Learning Test |
| IALT | International Adjuvant Lung cancer Trial |
| ICC | Intercostal catheter |
| IFRT | Involved field radiotherapy |
| IHC | Immunohistochemistry |
| IMRT | Intensity-modulated radiation therapy |
| LACE | Lung adjuvant cisplatin evaluation |
| LCNS | Lung Cancer Nurse Specialist |
| LUNG ART | Lung Adjuvant Radiotherapy Trial |
| MAb | Monoclonal antibody |
| MCGP | Meaning Centered Group Psychotherapy |
| MIR | Morphine Immediate release |
| MLD | Mean total lung dose |
| Mm/r | Morphine Modified release |
| MMPs | Matrix metalloproteinases |
| MMSE | Mini-mental status examination |
| MPE | Malignant pleural effusion |
| MRI | Magnetic resonance imaging |
| NCCTG | North Central Cancer Treatment Group |
| NNTB | Number needed to benefit |
| NNH | Number needed to harm |
| NNT | Number needed to treat |
| NSAIDS | Non-steroidal anti-inflammatory drugs |
| NSCLC | Non-small cell lung cancer |
| OS | Overall survival |
| PCI | Prophylactic cranial irradiation |
| PD | Progressive disease |
| PET scan | Positron emission tomography |
| PFS | Progression free survival |
| PORT | Postoperative external beam radiotherapy |
| PS | Performance status |
| PTV | Planning Target Volume |
| QALY | Quality Adjusted Life Years |
| QOL | Quality of life |
| QUANTEC | Quantitative Analysis of Normal Tissue Effects in the Clinic |
| RCT | Randomised controlled trial |
| RFA | Radiofrequency ablation |
| RR | Relative risk or Response rate |
| RT | Radiotherapy |
| RTOG | Radiation Therapy Oncology Group |
| SABR | Stereotactic ablative radiotherapy |
| SCC | Squamous cell carcinoma |
| SCLC | Small cell lung cancer |
| SCLC-LS | Small cell lung cancer - limited stage |
| SCLC-ES | Small cell lung cancer - extensive stage |
| SEER | Surveillance, Epidemiology and End Results |
| SGP | Supportive group psychotherapy |
| SMD | Standardised mean difference |
| SRS | Stereotactic radiosurgery |
| TAE | Transcathether arterial embolisation |
| TKIs | Tyrosine kinase inhibitors |
| TPC | Tunnelled pleural catheter |
| VAS | Visual analogue scale |
| VATS | Video-assisted thoracic surgery |
| VEGF | Vascular endothelial growth factor |
| WBRT | Whole brain radiotherapy |